CIK: 0001475373
申告総資産額
$4.2億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MDT | Medtronic plc | 株式-ヘルスケア | 7.57% | -0.16% | +19.99% | |
| 2 | MRK | Merck & Co. INC. | 株式-ヘルスケア | 7.43% | -1.33% | -2.05% | |
| 3 | BMY | Bristol-myers Squibb Co | 株式-ヘルスケア | 7.43% | +2.69% | -16.03% | |
| 4 | GILD | Gilead Sciences INC | 株式-ヘルスケア | 6.86% | -3.19% | +9.98% | |
| 5 | INCY | Incyte CORP | 株式-ヘルスケア | 5.82% | -0.47% | +3.23% | |
| 6 | RVTY | Revvity INC | 株式-ヘルスケア | 5.79% | — | -21.35% | |
| 7 | ALXN | Alexion Pharmaceuticals INC | 株式-その他 | 5.60% | — | +24.48% | |
| 8 | BSX | Boston Scientific CORP | 株式-ヘルスケア | 4.83% | — | -21.99% | |
| 9 | BIIB | Biogen INC | 株式-ヘルスケア | 4.35% | +0.47% | +4.86% | |
| 10 | ABT | Abbott Laboratories | 株式-ヘルスケア | 4.22% | +2.12% | NEW | |
| 11 | ELV | Elevance Health INC | 株式-ヘルスケア | 4.14% | +0.44% | -1.74% | |
| 12 | A | Agilent Technologies INC | 株式-ヘルスケア | 3.90% | — | -17.85% | |
| 13 | BRKR | Bruker CORP | 株式-ヘルスケア | 3.50% | -0.57% | +14.71% | |
| 14 | CVS | Cvs Health CORP | 株式-ヘルスケア | 3.35% | -0.91% | +75.56% | |
| 15 | NUVAGBP | Nuvasive INC | 株式-その他 | 3.20% | — | -7.12% | |
| 16 | CAH | Cardinal Health INC | 株式-ヘルスケア | 3.05% | -0.16% | +21.50% | |
| 17 | BIO | Bio-rad Laboratories-a | 株式-ヘルスケア | 2.99% | -0.08% | -3.11% | |
| 18 | ✓ | Laboratory CORP Amer Hldgs | 株式-その他 | 2.58% | — | — | |
| 19 | IONS | Ionis Pharmaceuticals INC | 株式-ヘルスケア | 2.55% | -0.34% | +24.40% | |
| 20 | PRGO | Perrigo Company plc | 株式-ヘルスケア | 2.27% | — | -25.40% | |
| 21 | JNJ | Johnson & Johnson | 株式-ヘルスケア | 1.94% | — | +88.63% | |
| 22 | HCA | Hca Healthcare INC | 株式-ヘルスケア | 1.87% | -1.15% | EXIT | |
| 23 | LIVN | LivaNova PLC | 株式-その他 | 1.48% | — | +31.39% | |
| 24 | ELAN | Elanco Animal Health INC | 株式-ヘルスケア | 1.27% | — | -22.40% | |
| 25 | RIGLUSD | Rigel Pharmaceuticals INC | 株式-その他 | 0.75% | — | — | |
| 26 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 0.65% | — | -53.24% | |
| 27 | CERNCHF | Cerner CORP | 株式-その他 | 0.43% | — | -69.38% | |
| 28 | CLVSEUR | Clovis Oncology INC | 株式-その他 | 0.21% | — | -55.54% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | MDT | Medtronic plc | +2.5% | +19.99% | 増加 |
| 2 | ALXN | Alexion Pharmaceuticals INC | +1.6% | +24.48% | 増加 |
| 3 | CVS | Cvs Health CORP | +1.4% | +75.56% | 増加 |
| 4 | HCA | Hca Healthcare INC | +1.2% | +86.97% | 増加 |
| 5 | JNJ | Johnson & Johnson | +1.1% | +88.63% | 増加 |
| 6 | MRK | Merck & Co. INC. | +1% | -2.05% | 減少 |
| 7 | BIIB | Biogen INC | +0.8% | +4.86% | 増加 |
| 8 | BRKR | Bruker CORP | +0.7% | +14.71% | 増加 |
| 9 | RVTY | Revvity INC | +0.6% | -21.35% | 減少 |
| 10 | BIO | Bio-rad Laboratories-a | +0.5% | -3.11% | 減少 |
| 11 | CAH | Cardinal Health INC | +0.5% | +21.50% | 増加 |
| 12 | LIVN | LivaNova PLC | +0.4% | +31.39% | 増加 |
| 13 | ELV | Elevance Health INC | +0.4% | -1.74% | 減少 |
| 14 | IONS | Ionis Pharmaceuticals INC | +0.2% | +24.40% | 増加 |
| 15 | A | Agilent Technologies INC | +0.1% | -17.85% | 減少 |
| 16 | ELAN | Elanco Animal Health INC | +0.1% | -22.40% | 減少 |
| 17 | GILD | Gilead Sciences INC | 0% | +9.98% | 増加 |
| 18 | INCY | Incyte CORP | -0.1% | +3.23% | 増加 |
| 19 | CLVSEUR | Clovis Oncology INC | -0.3% | -55.54% | 減少 |
| 20 | BSX | Boston Scientific CORP | -0.3% | -21.99% | 減少 |
| 21 | NUVAGBP | Nuvasive INC | -0.4% | -7.12% | 減少 |
| 22 | BMY | Bristol-myers Squibb Co | -0.4% | -16.03% | 減少 |
| 23 | ALNY | Alnylam Pharmaceuticals INC | -0.6% | -53.24% | 減少 |
| 24 | ABT | Abbott Laboratories | -0.7% | -35.02% | 減少 |
| 25 | CERNCHF | Cerner CORP | -0.8% | -69.38% | 減少 |
| 26 | PRGO | Perrigo Company plc | -1.1% | -25.40% | 減少 |
| 27 | HUM | Humana INC | — | EXIT | 全売却 |
| 28 | BMRN | Biomarin Pharmaceutical INC | — | EXIT | 全売却 |
| 29 | ✓ | Laboratory CORP Amer Hldgs | — | NEW | 新規購入 |
| 30 | PDCOEUR | Patterson Cos INC | — | EXIT | 全売却 |
| 31 | RARE | Ultragenyx Pharmaceutical In | — | EXIT | 全売却 |
| 32 | DGX | Quest Diagnostics INC | — | EXIT | 全売却 |
| 33 | PTCT | Ptc Therapeutics INC | — | EXIT | 全売却 |
| 34 | RIGLUSD | Rigel Pharmaceuticals INC | — | NEW | 新規購入 |